BOFAS Abstracts Archive

You can search for abstracts by using the search bar below.
Alternatively you can browse through podium and poster presentations by selecting the year and / or type below. You can further refine your search using tags or use the search bar.

 



Categories: Abstracts, 2015, Podium

Is Stimulan (synthetic calcium sulphate tablets impregnated with antibiotics) superior in the management of diabetic foot ulcers with osteomyelitis compared to standard treatment?

M. Raglan, S. Dhar, B. Scammell

1Nottingham University Hospital, Trauma and Orthopaedics, Nottingham, United Kingdom

2Nottingham University Hospital, Nottingham, United Kingdom 

Background: Diabetes is bad, common and diabetic foot ulcers (DFU) once established lead to high rates of amputation. In Nottingham our standard management for infected diabetic foot ulcers is surgical debridement, microbiological sampling, packing with gentamicin beads and targeted antibiotic therapy. Recently we have switched to packing with Stimulan, which is a purified synthetic calcium sulphate compound that can be mixed with patient appropriate antibiotics, is biodegradable and delivers better elution characteristics compared to gentamicin beads.

Aim: To assess the efficacy of Stimulan compared to Gentamicin beads in the surgical management of infected diabetic foot ulcers.

Methods: In 2012/13 the department audited its results of DFU surgical management with gentamicin beads. In 2014/5 the audit was repeated but Stimulan was used instead due to the perceived advantages Patients with infected DFU that could comply with treatment were included. Patients who had other sources of sepsis, non-compliant or moribund were excluded. Treatment pathways were identical apart for the use of Stimulan in 2014/5. The primary outcome measure was ulcer healing. The secondary outcome measure was length of stay and recurrence.

Results: Each group had 23 patients. The gentamicin group had a DFU for 12.3 months(3weeks-5 years) before presentation for surgery compared to the Stimulan group 6.1 months(2weeks-5years). Both groups had failed non-surgical management. The majority of the ulcers were located on the forefoot. In the stimulan group 70% (16/23) of ulcers had healed with an average of 4 months(2-7 months) compared to 57% (13/23) in the Gentamicin group within 6months(1-12). The length of stay was shorter in the Stimulan group 7 days (1-70) compared to 28days(1-70) in the Gentamicin group.

Conclusion: In our review Stimulan was superior to Gentamicin beads in the management of infected diabetic foot ulcers. We believe it has a role to play in limb salvage.

Previous Article Is operative treatment of delayed Achilles tendon rupture presentation essential? Mid and long-term follow-up of conservatively treated patients
Next Article Is the diagnosis of 5th metatarsal fracture subtype consistent? An inter-observer reliability study
Print


Click thumbnail below to view poster / thumbnail:

Archive of Abstracts

2024   -   Prize Winners  |  All Abstracts
2023   -   Prize Winners  |  All Abstracts
2022   -   Prize Winners  |  All Abstracts
2021   -   Prize Winners  
2019   -   Podium  |  Poster
2018   -   Podium  |  Poster
2017   -   Podium  |  Poster
2016   -   Podium  |  Poster
2015   -   Podium  |  Poster
2014   -   Podium  |  Poster
2013   -   Podium  |  Poster
2011   -   All Abstracts
2009   -   All Abstracts
2008   -   All Abstracts
2007   -   All Abstracts
2006   -   All Abstracts
2005   -   All Abstracts
2004   -   All Abstracts
2002   -   All Abstracts
2001   -   All Abstracts
2000   -   All Abstracts
1999   -   All Abstracts
1998   -   All Abstracts
1997   -   All Abstracts
1996   -   All Abstracts
1995   -   All Abstracts
1994   -   All Abstracts
1993   -   All Abstracts
1991   -   All Abstracts
1990   -   All Abstracts
1989   -   All Abstracts
1987   -   All Abstracts
1985   -   All Abstracts
1983   -   All Abstracts